ARCHIVES

Campath Improves PFS In B-Cell CLL In Phase III Trial

This article is from The Cancer Letter archive.

Vol. 30 No. 1 | January 26, 2007

Download PDF Visit The Full Archive

Related Articles

ACS Report Says Drop in Cancer Mortality Saved 898,000 Lives Over 17 Years

June 17, 2011

Clolar Approved for Pediatric Refractory/Relapsed ALL

January 28, 2005

FDA News: FDA Eases Two-Trial Standard For Proof Of Drug Efficacy

March 21, 1997

CTAC Discussion, Group Chairs Comment

December 17, 2010

Army Will Outspend NCI In Breast Cancer In FY93, But How To Apply For a Grant?

October 16, 1992

LAK/IL-2 Therapy Could Halt Kidney Cancer Deaths: DeVita

March 21, 1986